Strategies to develop selective CB2 receptor agonists from indole carboxamide synthetic cannabinoids.
Sign Up to like & getrecommendations! Published in 2019 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2019.07.036
Abstract: Activation of the CB2 receptor is an attractive therapeutic strategy for the treatment of a wide range of inflammatory diseases. However, receptor subtype selectivity is necessary in order to circumvent the psychoactive effects associated with… read more here.
Keywords: selective cb2; synthetic cannabinoids; cb2 receptor; develop selective ... See more keywords